
Novartis puts $12B on the table
Wall Street Breakfast
 00:00 
Novartis Agrees to Buy Avidity for $12B
Julie Morgan reports Novartis' $72-per-share offer for Avidity Biosciences and market reactions, including analyst commentary and related RNA winners.
 Transcript 
 Play full episode 


